Listing 1 - 10 of 849 | << page >> |
Sort by
|
Choose an application
Rising awareness about the potential link between vitamin D deficiency and adverse health outcomes has seen an increase in the rate of vitamin D testing in developed countries. The cost of a single vitamin D test is moderate (e.g., $61.32 in British Colombia) but the elevated testing rate contributes to substantial healthcare costs. Concern over rising costs led to reform in testing coverage in 2010 in Ontario, followed by other provinces. The changes in Ontario were based on a 2010 report by the Ontario Health Technology Advisory Committee (OHTAC) on the clinical utility of vitamin D testing (reviewed in this report). Despite a lack of direct evidence on testing, a recommendation was made against providing testing for the general population. Tests are now indicated only for individuals with specific conditions (i.e., osteoporosis, rickets, osteomalacia, malabsorption syndromes, renal disease, and individuals taking medications that may affect vitamin D status). The Endocrine Society and Osteoporosis Canada also recommend against screening for low risk individuals. There is a lack of evidence to suggest that the rise in test frequency has translated into improved healthcare practices. For example, the temporal increase in testing in Australia has not resulted in improved osteoporosis detection in women aged 45 to 74. There is also a lack of evidence on the cost-effectiveness of testing. In light of the rise in test frequency, assay and cut-off inconsistency, and the lack of evidence for the utility of testing, this report will investigate the clinical and cost-effectiveness of testing in the general population.
Vitamin D Deficiency --- Vitamin D Deficiency --- Vitamin D --- Diagnostic Techniques and Procedures --- Cost-Benefit Analysis --- diagnosis. --- economics. --- analysis. --- economics. --- Canada
Choose an application
The purpose of this report is to review the diagnostic accuracy of methods for the identification of shiga toxigenic E.coli (STEC), the clinical utility of STEC testing, the cost-effectiveness of STEC screening, and the evidence-based guidelines regarding STEC screening.
Escherichia coli Infections --- Bacterial Typing Techniques --- Shiga-Toxigenic Escherichia coli --- diagnosis. --- economics. --- isolation & purification. --- Escherichia coli infections --- Escherichia coli O157:H7. --- Medical screening --- Biology --- Escherichia coli o157:h7 --- Health --- Health sciences --- Medical specialties --- Medicine --- Reverse transcription polymerase chain reaction --- Clinical medicine --- Evidence-based medicine --- Microbiology --- Diagnosis. --- Evaluation.
Choose an application
Debridement is the removal of necrotic tissue, foreign debris, bacterial growth, callus, wound edge, and wound bed tissue from chronic wounds in order to stimulate the wound healing process. Stimulation of wound healing mediated by debridement is thought to occur by the conversion of a chronic non-healing wound environment to an acute healing environment through the removal of cells that are not responsive to endogenous healing stimuli. Debridement is used commonly in standard wound treatment of diabetic foot ulcers (DFUs). Methods of debridement include surgery (sharp debridement), chemical debridement (antiseptics, polysaccharide beads, pastes), autolytic (hydrogels, hydrocolloids and transparent films), biosurgery (maggots), mechanical (hydrodebridement), and biochemical debridement (enzyme preparations). Callus is a buildup of keratinized skin formed under conditions of repeated pressure or friction and may contribute to ulcer formation by creating focal areas of high plantar pressure. The debridement of callus has been proposed to be relevant for both treatment and prevention of DFU. The purpose of this report is to retrieve and review existing evidence of comparative clinical effectiveness of different methods of debridement for the treatment of DFUs. Additionally examined in this report is the clinical effectiveness for treatment and prevention of DFU using callus debridement. Cost-effectiveness, and existing debridement guidelines for the treatment of DFUs will also be reviewed.
Diabetic Foot --- Debridement --- Treatment Outcome --- Cost-Benefit Analysis --- surgery. --- economics. --- methods. --- Canada --- Foot --- Debridement. --- Diabetes --- Wireless communication systems --- Patient monitoring --- Foot Ulcer --- Diabetes Complications --- Chronic wound --- Clinical medicine --- Clinical trial --- Cohort study --- Diabetic foot ulcer --- Health --- Health care --- Health sciences --- Medical guideline --- Ulcers --- Complications --- Safety measures. --- Equipment and supplies. --- therapy.
Choose an application
Bariatric surgery has been proven to be more effective than other measures such as medications and lifestyle interventions for weight loss. There are a number of bariatric surgical procedures currently available, and the most commonly performed procedures are Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and laparoscopic adjustable gastric banding (LAGB). RYGB involves restricting the size of the stomach to create a much smaller gastric pouch, and attaching the pouch to the mid-jejunum, resulting in malabsorption of food. SG involves removing the greater fundus and curvature of the stomach, creating a much smaller tube-like stomach, thereby restricting food intake. LAGB uses a band that is encircled around the top of the stomach. The band is connected to a subcutaneous port that can be used to inflate the band, increasing the restriction on the stomach. Each procedure is associated with benefits and risks; therefore, the purpose of this review is to compare the clinical effectiveness, safety, and cost-effectiveness of the RYGB, SG, and LAGB procedures amongst one another in obese and morbidly obese patients. This report builds on a Rapid Response report completed in August 2013, which focused on the evidence for prioritizing patients for bariatric surgery.
Bariatric Surgery --- Obesity --- Treatment Outcome --- Cost-Benefit Analysis --- Evidence-Based Medicine --- surgery. --- Canada
Choose an application
The purpose of this report is to review the available evidence on the clinical efficacy and safety of vaginally administered micronized progesterone capsules for the prevention of miscarriage and preterm birth.
Progesterone --- Progesterone --- Capsules --- Abortion, Spontaneous --- Premature Birth --- Treatment Outcome --- administration & dosage. --- therapeutic use. --- prevention & control. --- prevention & control. --- Canada
Choose an application
Technology Assessment, Biomedical. --- Biomedical Technology.
Choose an application
Technology Assessment, Biomedical. --- Biomedical Technology.
Choose an application
Rising awareness about the potential link between vitamin D deficiency and adverse health outcomes has seen an increase in the rate of vitamin D testing in developed countries. The cost of a single vitamin D test is moderate (e.g., $61.32 in British Colombia) but the elevated testing rate contributes to substantial healthcare costs. Concern over rising costs led to reform in testing coverage in 2010 in Ontario, followed by other provinces. The changes in Ontario were based on a 2010 report by the Ontario Health Technology Advisory Committee (OHTAC) on the clinical utility of vitamin D testing (reviewed in this report). Despite a lack of direct evidence on testing, a recommendation was made against providing testing for the general population. Tests are now indicated only for individuals with specific conditions (i.e., osteoporosis, rickets, osteomalacia, malabsorption syndromes, renal disease, and individuals taking medications that may affect vitamin D status). The Endocrine Society and Osteoporosis Canada also recommend against screening for low risk individuals. There is a lack of evidence to suggest that the rise in test frequency has translated into improved healthcare practices. For example, the temporal increase in testing in Australia has not resulted in improved osteoporosis detection in women aged 45 to 74. There is also a lack of evidence on the cost-effectiveness of testing. In light of the rise in test frequency, assay and cut-off inconsistency, and the lack of evidence for the utility of testing, this report will investigate the clinical and cost-effectiveness of testing in the general population.
Vitamin D Deficiency --- Vitamin D Deficiency --- Vitamin D --- Diagnostic Techniques and Procedures --- Cost-Benefit Analysis --- diagnosis. --- economics. --- analysis. --- economics. --- Canada
Choose an application
Rising awareness about the potential link between vitamin D deficiency and adverse health outcomes has seen an increase in the rate of vitamin D testing in developed countries. The cost of a single vitamin D test is moderate (e.g., $61.32 in British Colombia) but the elevated testing rate contributes to substantial healthcare costs. Concern over rising costs led to reform in testing coverage in 2010 in Ontario, followed by other provinces. The changes in Ontario were based on a 2010 report by the Ontario Health Technology Advisory Committee (OHTAC) on the clinical utility of vitamin D testing (reviewed in this report). Despite a lack of direct evidence on testing, a recommendation was made against providing testing for the general population. Tests are now indicated only for individuals with specific conditions (i.e., osteoporosis, rickets, osteomalacia, malabsorption syndromes, renal disease, and individuals taking medications that may affect vitamin D status). The Endocrine Society and Osteoporosis Canada also recommend against screening for low risk individuals. There is a lack of evidence to suggest that the rise in test frequency has translated into improved healthcare practices. For example, the temporal increase in testing in Australia has not resulted in improved osteoporosis detection in women aged 45 to 74. There is also a lack of evidence on the cost-effectiveness of testing. In light of the rise in test frequency, assay and cut-off inconsistency, and the lack of evidence for the utility of testing, this report will investigate the clinical and cost-effectiveness of testing in the general population.
Vitamin D Deficiency --- Vitamin D Deficiency --- Vitamin D --- Diagnostic Techniques and Procedures --- Cost-Benefit Analysis --- diagnosis. --- economics. --- analysis. --- economics. --- Canada
Choose an application
Pharmaceutical technology --- Medical tehnology --- Technology Assessment, Biomedical. --- Medical Laboratory Science. --- Technology, Pharmaceutical. --- Pharmaceutical technology. --- Evaluation --- Assessment, Biomedical Technology --- Assessment, Technology --- Biomedical Technology Assessment --- Technology Assessment --- Technology Assessment, Health --- Assessment, Health Technology --- Assessments, Biomedical Technology --- Assessments, Health Technology --- Assessments, Technology --- Biomedical Technology Assessments --- Health Technology Assessment --- Health Technology Assessments --- Technology Assessments --- Technology Assessments, Biomedical --- Technology Assessments, Health --- Pharmaceutical laboratory techniques --- Pharmaceutical laboratory technology --- Technology, Pharmaceutical --- Technology --- Pharmaceutic Technology --- Pharmaceutical Technology --- Pharmacy Technology --- Technology, Pharmaceutic --- Technology, Pharmacy --- Chemistry, Pharmaceutical --- Drug Industry --- Clinical Laboratory Science --- Medical Laboratory Technology --- Technology, Medical Laboratory --- Clinical Laboratory Sciences --- Laboratory Science, Clinical --- Laboratory Science, Medical --- Laboratory Sciences, Clinical --- Laboratory Sciences, Medical --- Laboratory Technologies, Medical --- Laboratory Technology, Medical --- Medical Laboratory Sciences --- Medical Laboratory Technologies --- Science, Clinical Laboratory --- Science, Medical Laboratory --- Sciences, Clinical Laboratory --- Sciences, Medical Laboratory --- Technologies, Medical Laboratory --- Medical Laboratory Personnel --- Clinical Laboratory Techniques --- Medical technology --- Evaluation. --- Canada. --- Health care technology --- Health technology
Listing 1 - 10 of 849 | << page >> |
Sort by
|